Search results
Results from the WOW.Com Content Network
Because of AAV's specialized gene therapy advantages, researchers have created an altered version of AAV termed self-complementary adeno-associated virus (scAAV). Whereas AAV packages a single strand of DNA and must wait for its second strand to be synthesized, scAAV packages two shorter strands that are complementary to each other.
Self-complementary adeno-associated virus (scAAV) is a viral vector engineered from the naturally occurring adeno-associated virus (AAV) to be used as a tool for gene therapy. [1] Use of recombinant AAV (rAAV) has been successful in clinical trials addressing a variety of diseases. [ 2 ]
Recombinant adeno-associated virus (rAAV) based genome engineering is a genome editing platform centered on the use of recombinant AAV vectors that enables insertion, deletion or substitution of DNA sequences into the genomes of live mammalian cells.
The DisGeNET database integrates over 400 000 associations between > 17 000 genes and > 14 000 diseases from human to animal model expert curated databases with text mined GDAs from MEDLINE using a NLP-based approach. [4] The highlights of DisGeNET are the data integration, standardisation and a fine-grained tracking of the provenance information.
This list of laboratory biosecurity incidents includes accidental laboratory-acquired infections and laboratory releases of lethal pathogens, containment failures in or during transport of lethal pathogens, and incidents of exposure of lethal pathogens to laboratory personnel, improper disposal of contaminated waste, and/or the escape of laboratory animals.
Protection policy may refer to: Policies. Information protection policy; Data protection policy; Planetary protection policy; Whistleblower protection policy; Environmental protection policy; Farmland protection policy; Child protection policy; Cultural heritage protection policy; Finance. Income protection policy; Payment protection policy ...
ClinVar is a public archive with free access to reports on the relationships between human variations and phenotypes, with supporting evidence.The database includes germline and somatic variants of any size, type or genomic location.
In 2009 SIB disconnected the database from the GISAID portal over a contract dispute, resulting in litigation. [38] [4] [39] In April 2010 the Federal Republic of Germany announced during the 7th International Ministerial Conference on Avian and Pandemic Influenza in Hanoi, Vietnam, that GISAID had entered into a cooperation agreement [40] with the German government, making Germany the long ...